Spago Nanomedical AB (publ) (STO:SPAGO)
Sweden · Delayed Price · Currency is SEK 0.1195
+0.0020 (1.70%)
Mar 4, 2026, 3:14 PM CET
Spago Nanomedical AB Market Cap
Spago Nanomedical AB has a market cap or net worth of 79.06 million as of March 4, 2026. Its market cap has increased by 8.12% in one year.
Market Cap
79.06M
Enterprise Value
49.39M
Revenue
4.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since January 16, 2013, Spago Nanomedical AB's market cap has increased from 46.44M to 79.06M, an increase of 70.23%. That is a compound annual growth rate of 4.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 79.06M | 2.58% |
| Dec 30, 2025 | 77.07M | 12.93% |
| Dec 30, 2024 | 68.25M | -4.38% |
| Dec 29, 2023 | 71.37M | 24.57% |
| Dec 30, 2022 | 57.29M | -71.02% |
| Dec 30, 2021 | 197.67M | -26.79% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 128.23M |
| Annexin Pharmaceuticals AB | 110.12M |
| Biovica International AB | 109.47M |
| Alligator Bioscience AB | 102.73M |
| Biosergen AB | 90.17M |
| Scandinavian ChemoTech AB | 89.34M |
| OncoZenge AB | 78.54M |
| Alzinova AB | 64.05M |